Data is not available at this time.
EnWave Corporation operates as a specialized industrial technology company focused on commercializing its proprietary Radiant Energy Vacuum (REV) dehydration platforms. The company generates revenue through a dual-stream model: selling and licensing its vacuum-microwave machinery to food producers, cannabis companies, and pharmaceutical manufacturers, while also operating a direct-to-consumer business selling dehydrated cheese snacks under the Moon Cheese brand. This positions EnWave at the intersection of industrial equipment manufacturing and advanced food processing technology, serving clients who require precise moisture removal for product preservation, shelf-life extension, and quality maintenance. The company's technology competes against traditional dehydration methods like air drying and freeze drying by offering faster processing times and superior product quality retention. EnWave's market position is that of a niche technology innovator, leveraging patents to protect its intellectual property while seeking to establish industry standards for microwave-vacuum dehydration across multiple sectors including snacks, cannabis, and pharmaceuticals. Their direct consumer products serve as both a revenue source and a demonstration platform for their technology's capabilities.
EnWave reported revenue of CAD 8.18 million for the fiscal year, reflecting its current scale as a developing technology company. The company operated at a net loss of CAD 2.40 million, indicating ongoing investment requirements despite generating positive operating cash flow of CAD 1.39 million. Capital expenditures were modest at CAD 218,000, suggesting a capital-light approach to business expansion. The negative earnings per share of CAD 0.0216 reflects the company's current pre-profitability stage as it continues to commercialize its REV technology platform across multiple industries.
The company demonstrates emerging operational viability through its positive operating cash flow generation, which exceeded capital investment requirements. The current earnings profile reflects significant investment in technology commercialization and market development activities. EnWave's capital efficiency appears reasonable given its development stage, with operating cash flow covering substantial portions of its operational needs while maintaining a focused approach to capital deployment in growth initiatives across its equipment sales, licensing, and direct-to-consumer segments.
EnWave maintains a conservative financial structure with CAD 4.76 million in cash and equivalents against total debt of CAD 1.57 million, providing adequate liquidity for near-term operations. The company's balance sheet reflects a development-stage technology firm with sufficient cash reserves to fund ongoing operations while pursuing growth opportunities. The modest debt level suggests limited financial leverage, providing flexibility for strategic initiatives without significant interest burden constraints.
As a growth-oriented technology company, EnWave does not pay dividends, instead reinvesting capital into business development and technology commercialization. The company's growth strategy focuses on expanding adoption of its REV technology across food, cannabis, and pharmaceutical sectors while developing its direct-to-consumer snack business. Current financial trends reflect the challenges of scaling a novel technology platform while managing the capital requirements of multiple business segments in development phase.
With a market capitalization of approximately CAD 42.86 million, the market appears to be valuing EnWave based on its technology potential rather than current financial performance. The beta of 0.989 suggests stock volatility roughly in line with the broader market. The valuation reflects investor expectations for future technology adoption and revenue growth across the company's target markets, particularly as the REV platform gains traction in commercial applications.
EnWave's primary strategic advantage lies in its patented REV dehydration technology, which offers differentiated performance characteristics compared to conventional methods. The company's outlook depends on successful commercialization across its target markets and scaling its equipment sales and licensing operations. Key challenges include achieving critical mass in technology adoption, managing cash burn during development phases, and demonstrating sustainable profitability across its diversified business model while navigating competitive pressures in industrial dehydration markets.
Company financial statementsTSXV filingsCorporate description
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |